Single-tablet regimen with elvitegravir, cobicistat, emtricitabine and tenofovir for the treatment of early HIV infection

被引：0
|
作者：
Teira, Ramon [1 ]
Galindo, Maria [2 ]
Montero, Marta [3 ]
Portilla, Raquel [4 ]
Ferrer, Ana [2 ]
Martinez, Elisa [5 ]
机构：
[1] Hosp Sierrallana, Infect Dis, Torrelavega, Spain
[2] Hosp Clin, Infect Dis, Valencia, Spain
[3] Hosp La Fe, Infect Dis, Valencia, Spain
[4] Hosp Sierrallana, Internal Med, Torrelavega, Spain
[5] Hosp Albacete, Internal Med, Albacete, Spain
来源：
JOURNAL OF THE INTERNATIONAL AIDS SOCIETY | 2016年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
P052
引用
收藏
页数：2
相关论文
共 50 条
  • [1] An evaluation of elvitegravir plus cobicistat plus tenofovir alafenamide plus emtricitabine as a single-tablet regimen for the treatment of HIV in children and adolescents
    Giacomet, Vania
    Cossu, Maria V.
    Capetti, Amedeo F.
    Zuccotti, GianVincenzo
    Rizzardini, Giuliano
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2019, 20 (03) : 269 - 276
  • [2] A Randomized, Double-Blind Comparison of Single-Tablet Regimen Elvitegravir/Cobicistat/Emtricitabine/Tenofovir DF Versus Single-Tablet Regimen Efavirenz/Emtricitabine/Tenofovir DF for Initial Treatment of HIV-1 Infection: Analysis of Week 144 Results
    Wohl, David A.
    Cohen, Calvin
    Gallant, Joel E.
    Mills, Anthony
    Sax, Paul E.
    DeJesus, Edwin
    Zolopa, Andrew
    Liu, Hui C.
    Plummer, Andrew
    White, Kirsten L.
    Cheng, Andrew K.
    Rhee, Martin S.
    Szwarcberg, Javier
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2014, 65 (03) : E118 - E121
  • [3] Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single Tablet for HIV-1 Infection Treatment
    Olin, Jacqueline L.
    Spooner, Linda M.
    Klibanov, Olga M.
    [J]. ANNALS OF PHARMACOTHERAPY, 2012, 46 (12) : 1671 - 1677
  • [4] Elvitegravir-Cobicistat-Emtricitabine-Tenofovir Alafenamide Single-tablet Regimen for Human Immunodeficiency Virus Postexposure Prophylaxis
    Gantner, Pierre
    Hessamfar, Mojgan
    Souala, Mohamed Faouzi
    Valin, Nadia
    Simon, Anne
    Ajana, Faiza
    Bouvet, Elisabeth
    Rouveix, Elisabeth
    Cotte, Laurent
    Bani-Sadr, Firouze
    Hustache-Mathieu, Laurent
    Lebrette, Marie-Gisele
    Truchetet, Francois
    Galempoix, Jean-Marie
    Piroth, Lionel
    Pellissier, Gerard
    Muret, Patrice
    Rey, David
    [J]. CLINICAL INFECTIOUS DISEASES, 2020, 70 (05) : 943 - 946
  • [5] Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Stribild®): A Review of Its Use in the Management of HIV-1 Infection in Adults
    Caroline M. Perry
    [J]. Drugs, 2014, 74 : 75 - 97
  • [6] Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate Single-Tablet Regimen (Stribild®): A Review of Its Use in the Management of HIV-1 Infection in Adults
    Perry, Caroline M.
    [J]. DRUGS, 2014, 74 (01) : 75 - 97
  • [7] Switching to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate single-tablet regimen (Stribild®): effects on T-cell compartment and HIV reservoirs
    Merlini, Esther
    Cazzaniga, Federico
    Casabianca, Anna
    Orlandi, Chiara
    Ancona, Giuseppe
    Cogliandro, Viola
    Tincati, Camilla
    Bini, Teresa
    Magnani, Mauro
    Monforte, Antonella d'Arminio
    Marchetti, Giulia
    [J]. JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2016, 19
  • [8] Efficacy and Safety of Switching to a Single-Tablet Regimen of Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide in HIV-1/Hepatitis B-Coinfected
    Gallant, Joel
    Brunetta, Jason
    Crofoot, Gordon
    Benson, Paul
    Mills, Anthony
    Brinson, Cynthia
    Oka, Shinichi
    Cheng, Andrew
    Garner, Will
    Fordyce, Marshall
    Das, Moupali
    McCallister, Scott
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 73 (03) : 294 - 298
  • [9] Efficacy of single-tablet darunavir, cobicistat, emtricitabine, and tenofovir alafenamide in the treatment of HIV-1
    Negredo, Eugenia
    Clotet, Bonaventura
    [J]. EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (08) : 929 - 934
  • [10] Randomized, phase 2 evaluation of two single-tablet regimens elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate for the initial treatment of HIV infection
    Cohen, Calvin
    Elion, Richard
    Ruane, Peter
    Shamblaw, David
    DeJesus, Edwin
    Rashbaum, Bruce
    Chuck, Steven L.
    Yale, Kitty
    Liu, Hui C.
    Warren, David R.
    Ramanathan, Srinivasan
    Kearney, Brian P.
    [J]. AIDS, 2011, 25 (06) : F7 - F12
12345